Biparametric MRI for High-Risk Prostate Cancer Screening
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort
Recruiting
N/AInterventional Study
Prostate CancerMagnetic Resonance ImagingPopulation at Risk
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
40 – 55
Sex
Male
Study type
Interventional
Purpose
Screening
Participants needed
100 (estimated)
Sponsor
Northwell Health · Other
Who this trial is looking for
This trial is looking for men at high risk of developing prostate cancer to see if a specific type of MRI can help improve screening. Participants will work with doctors to monitor their prostate health.
Are You a Good Fit for This Trial?
You may be able to join if
I have a PSA level between 1.0 and 2.5 ng/dL
I identify as Black or have a close relative who had prostate cancer
I am willing to participate in prostate cancer screening
I can give informed consent
You may not be able to join if
I have a firm or lumpy prostate on exam
I have had a biopsy or surgery on my prostate before
I am taking 5-alpha reductase inhibitors for prostate issues
I have had a UTI or prostatitis in the last 6 months
I have a condition that makes MRI unsafe for me
I experience claustrophobia, anxiety, or vertigo in MRI machines
I cannot lie flat for the duration of the study
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
To determine whether using bpMRI in subjects who are at high risk of developing prostate cancer in conjunction with PSA will improve prostate cancer screening protocols.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
1. PSA between 1.0 and 2.5 ng/dL
2. High risk for prostate cancer, i.e. Black or they have a first degree relative with history of prostate cancer (father, brother) or specific genetic syndromes i.e. BRCA 1/2, HOX B13, Lynch syndrome, ATM, CHEK2
3. Patient is willing to particip…
Inclusion Criteria:
1. PSA between 1.0 and 2.5 ng/dL
2. High risk for prostate cancer, i.e. Black or they have a first degree relative with history of prostate cancer (father, brother) or specific genetic syndromes i.e. BRCA 1/2, HOX B13, Lynch syndrome, ATM, CHEK2
3. Patient is willing to participated in prostate cancer screening
4. Patient is capable of giving informed consent
Exclusion Criteria:
1. Nodularity or firmness of prostate on exam
2. Patient has undergone a prior biopsy or prostate surgery
3. Patient is taking 5-alpha reductase inhibitors to manage benign prostatic hyperplasia, as this can significantly alter PSA levels.
4. Patient has a history of UTI or prostatitis in the preceding 6 months, as this can significantly alter PSA levels.
5. Patient has a contraindication to MRI, these include but are not limited to pacemakers, neurostimulator devices, metal cardiac valves, certain tattoos, or foreign bodies
6. Participants that experience claustrophobia, anxiety and/or vertigo when moved inside the scanner
7. The participant cannot tolerate lying flat for the study duration
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
